IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma
Authors:
- 14 November 2016
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (22) , 6543-6554
Abstract
The molecular basis underlying the particularly aggressive nature of pancreatic ductal adenocarcinoma (PDAC) still remains unclear. Here we report evidence that the insulin-like growth factor–binding protein IGFBP2 acts as a potent oncogene to drive its extremely malignant character. We found that elevated IGFBP2 expression in primary tumors was associated with lymph node metastasis and shorter survival in patients with PDAC. Enforced expression of IGFBP2 promoted invasion and metastasis of PDAC cells in vitro and in vivo by inducing NF-κB–dependent epithelial–mesenchymal transition (EMT). Mechanistic investigations revealed that IGFBP2 induced the nuclear translocation and phosphorylation of the p65 NF-κB subunit through the PI3K/Akt/IKKβ pathway. Conversely, enforced expression of PTEN blunted this signaling pathway and restored an epithelial phenotype to PDAC cells in the presence of overexpressed IGFBP2. Overall, our results identify IGFBP2 as a pivotal regulator of an EMT axis in PDAC, the activation of which is sufficient to confer the characteristically aggressive clinical features of this disease. Cancer Res; 76(22); 6543–54. ©2016 AACR.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkProceedings of the National Academy of Sciences, 2012
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Interferon Regulatory Factor 2 Binding Protein 2 Is a New NFAT1 Partner and Represses Its Transcriptional ActivityMolecular and Cellular Biology, 2011
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic AdenocarcinomaJNCI: Journal of the National Cancer Institute, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomasProceedings of the National Academy of Sciences, 2009
- Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and InvasionCancer Cell, 2009
- Insulin-like growth factor binding protein 2 promotes glioma development and progressionProceedings of the National Academy of Sciences, 2007
- Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancerProceedings of the National Academy of Sciences, 2007
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI: Journal of the National Cancer Institute, 2000